{"id":"W3158712737","doi":"10.1038/s41591-021-01317-6","title":"An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Biomarker; Medicine; PARP inhibitor; Bladder cancer; Oncology; Cancer research; Cancer; Targeted therapy; Urothelium; Internal medicine; Immunotherapy; Biology; Nivolumab; Poly ADP ribose polymerase; DNA; Urinary bladder","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001896196,0.0002347097,0.0006397074,0.0003339469,0.00003041899,0.00000351739,0.00008697461,0.0001888992,0.0002589857],"category_scores_gemma":[0.00008094066,0.0001584158,0.00002656882,0.001185596,0.00008643709,0.0001317559,0.00001332188,0.0005007007,5.462757e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002090627,"about_ca_system_score_gemma":0.0003061686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002226343,"about_ca_topic_score_gemma":0.01197996,"domain_scores_codex":[0.9983037,0.000111558,0.0003785301,0.0004008173,0.0005717056,0.0002337624],"domain_scores_gemma":[0.9990759,0.00006767327,0.0001223655,0.0003160281,0.0003295764,0.00008841611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0328312,0.01279499,0.7048006,0.0002526266,0.0009577762,0.001590318,0.02420882,0.0000873935,0.1165294,0.0001996465,0.0001817233,0.1055655],"study_design_scores_gemma":[0.05140961,0.008348281,0.9191741,0.0008156044,0.0001732448,0.00002710535,0.007270154,0.0003808661,0.01187526,0.0001093388,0.0002325147,0.0001839362],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912491,0.005615339,0.00001054901,0.000793711,0.0002438116,0.001138369,0.00002044819,0.00005692629,0.0008716832],"genre_scores_gemma":[0.9986697,0.0002255272,0.0002958477,0.0003125937,0.00007570534,0.0001355059,0.00008894403,0.0000349161,0.0001612378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2143735,"threshold_uncertainty_score":0.6685097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01968541919565534,"score_gpt":0.3248717961462149,"score_spread":0.3051863769505595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}